IPN10200 treatment for cervical dystonia in adults
A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants
This trial will test whether a single injection of IPN10200 (one of two doses) reduces neck posture problems, pain, and disability better than placebo in adults with cervical dystonia.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Enrollment | 132 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Ipsen Industry-sponsored |
| Locations | 44 sites (Tucson, Arizona and 43 other locations) |
| Trial ID | NCT06937931 on ClinicalTrials.gov |
What this trial studies
This Phase 2, placebo-controlled interventional trial enrolls adults with isolated cervical dystonia and required minimum symptom scores on the TWSTRS scale. After a screening period of up to 4 weeks, participants enter a 36-week treatment period in which they receive either IPN10200 (Dose A or Dose B) or placebo on Day 1 and are followed for efficacy and safety outcomes. The protocol allows both patients who are naïve to botulinum toxin (BoNT) and those previously treated with BoNT. Key eligibility limits include exclusion of severe dysphagia, predominant antero- or retrocollis, traumatic or tardive torticollis, and marked cervical contractures.
Who should consider this trial
Good fit: Adults with isolated cervical dystonia who meet TWSTRS thresholds (Total ≥20; Severity ≥15; Disability ≥3; Pain ≥1) who do not have severe dysphagia or predominant antero/retrocollis are the intended participants, and both BoNT-naïve and previously treated patients may be eligible.
Not a fit: Patients with severe dysphagia, predominant anterocollis or retrocollis, traumatic or tardive torticollis, marked cervical contractures, or other exclusionary conditions are unlikely to be eligible or to benefit from this investigational treatment.
Why it matters
Potential benefit: If successful, IPN10200 could provide longer-lasting relief of neck posture, pain, and disability than current botulinum toxin injections, reducing how often patients need injections.
How similar studies have performed: Botulinum toxin injections are an established short-term treatment for cervical dystonia but typically last about three months, and long-acting formulations like IPN10200 are relatively novel with limited prior clinical data.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. A clinical diagnosis of isolated Cervical Dystonia (CD) (idiopathic) characterized by dystonic symptoms localised to the head, neck, and shoulder areas with at least moderate severity at Screening and Baseline (Day 1) defined as: * (a) Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)-Total score ≥20 * (b) TWSTRS-Severity subscale score ≥15 * (c) TWSTRS-Disability subscale score ≥3 * (d) TWSTRS-Pain subscale score ≥ 1 2. Treatment naïve or non-naïve to BoNT therapy for CD Exclusion Criteria: 1. Participants presenting with a swallowing disorder of any origin which might be exacerbated by BoNT treatment, such as: * (a) Grade 3 or 4 on the Dysphagia Severity Scale (severe dysphagia) with swallowing difficulties and requiring a change in diet. 2. Predominant anterocollis. 3. Predominant retrocollis. 4. Traumatic torticollis or tardive torticollis. 5. Marked limitation on passive range of motion that suggests cervical contractures or structural abnormality.
Where this trial is running
Tucson, Arizona and 43 other locations
- University of Arizona Health Sciences - Neurology — Tucson, Arizona, United States (Active_not_recruiting)
- Parkinson's & Mvmt Disorders Inst — Fountain Valley, California, United States (Recruiting)
- Parkinson's Ds & Mvt Disorders Cntr — Boca Raton, Florida, United States (Recruiting)
- USF Health Byrd Alzheimer's Institute — Tampa, Florida, United States (Not_yet_recruiting)
- Emory Brain Health Center — Atlanta, Georgia, United States (Recruiting)
- Rush Medical Center — Chicago, Illinois, United States (Active_not_recruiting)
- Quest Research Institute — Farmington Hills, Michigan, United States (Recruiting)
- Ichan Sch of Medicine @ Mt. Sinai — New York, New York, United States (Recruiting)
- Kingfisher Cooperative — Spokane, Washington, United States (Recruiting)
- Fakultni nemocnice u sv. Anny v Brne - I. Neurologicka klinika — Brno, Czechia (Recruiting)
- MINKSneuro s.r.o. — Brno, Czechia (Active_not_recruiting)
- NEUROHK s.r.o. — Choceň, Czechia (Recruiting)
- Fakultni nemocnice Olomouc - Neurologicka klinika — Olomouc, Czechia (Not_yet_recruiting)
- Vseobecna fakultni nemocnice v Praze - Neurologicka klinika — Prague, Czechia (Withdrawn)
- CHU Grenoble Alpes - Site Nord - Neurology — Grenoble, France (Recruiting)
- Timone University Hospital — Marseille, France (Active_not_recruiting)
- CHU Nimes - Hôpital Caremeau — Nîmes, France (Recruiting)
- Hopitaux Universitaire de Strasbourg - Hopital de Hautepierre - Neurologie — Strasbourg, France (Active_not_recruiting)
- Centre Hospitalier Universitaire (CHU) Purpan - Institut Des Sciences du Cerveau De Toulouse (Institute for Brain Sciences) — Toulouse, France (Recruiting)
- Curiositas ad sanum Studien- und Beratungs GmbH Haag i.OB - Neurologie — Haag in Oberbayern, Germany (Recruiting)
- Universitätsklinikum Hamburg-Eppendorf — Hamburg, Germany (Not_yet_recruiting)
- GFO Kliniken Troisdorf — Troisdorf, Germany (Recruiting)
- University Hospital Tuebingen - Neurologie — Tübingen, Germany (Active_not_recruiting)
- Ospedale Bellaria, IRCCS Istituto delle Scienze Neurologiche, AUSL Bologna — Bologna, Italy (Recruiting)
- Istituto Auxologico Italiano - Auxologico San Luca — Milan, Italy (Recruiting)
- Istituto Neurologico C. Besta — Milan, Italy (Active_not_recruiting)
- IRCCS C.Mondino, Istituto Neurologico Nazionale, Fondazione — Pavia, Italy (Recruiting)
- Azienda USL-IRCCS di Reggio Emilia - Presidio ospedaliero provinciale sede di Reggio Emilia — Reggio Emilia, Italy (Not_yet_recruiting)
- Specjalistyczna Praktyka Lekarska Dr Stanislaw Ochudlo — Katowice, Poland (Withdrawn)
- Futuremeds Krakow — Krakow, Poland (Recruiting)
- SP ZOZ Szpital Uniwersytecki w Krakowie — Krakow, Poland (Recruiting)
- Instytut Zdrowia Dr Boczarska-Jedynak Sp. z o.o. S.K. — Oświęcim, Poland (Recruiting)
- Eskulap Pabianice Sp z o.o. — Pabianice, Poland (Recruiting)
- ETG Neuroscience Sp. z o.o. — Warsaw, Poland (Recruiting)
- Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego — Wroclaw, Poland (Withdrawn)
- Hospital de la Santa Creu i Sant Pau - Neurología — Barcelona, Spain (Active_not_recruiting)
- H.U. Puerta del Mar - Neurocirugía — Cadiz, Spain (Recruiting)
- Hospital Universitario De La Princesa — Madrid, Spain (Recruiting)
- Hospital Universitario Ramon y Cajal - Neurologia — Madrid, Spain (Withdrawn)
- Hospital Universitario Virgen del Rocio - Neurofisiología Clínica — Seville, Spain (Recruiting)
- Royal Devon And Exeter Hospital - Neurology — Exeter, United Kingdom (Not_yet_recruiting)
- The Walton Centre — Fazakerley, United Kingdom (Recruiting)
- University College London Hospitals NHS Foundation Trust - National Hospital for Neurology and Neurosurgery — London, United Kingdom (Recruiting)
- Luton And Dunstable Hospital - Neurology — Luton, United Kingdom (Active_not_recruiting)
Study contacts
- Study coordinator: Ipsen Clinical Study Enquiries
- Email: clinical.trials@ipsen.com
- Phone: See e mail
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.